A Brief History of FDA Compounding Oversight

被引：0

|

作者：

Shulman, Stanford T. ^{[1
,2
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA

[2] Ann & Robert H Lurie Childrens Hosp, Div Infect Dis, Chicago, IL USA

来源：

PEDIATRIC ANNALS | 2013年 / 42卷 / 01期

关键词：

D O I：

10.3928/00904481-20121221-01

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

收藏

页数：2

相关论文

共 50 条

[41] FDA's Framework for Regulatory Oversight of LDTs
Pathak, Bhagyashri
Terry, Sharon F.
GENETIC TESTING AND MOLECULAR BIOMARKERS, 2014, 18 (12) : 785 - 786
[42] Outsourcing challenges FDA to strengthen oversight abroad
Torres, Christian
NATURE MEDICINE, 2010, 16 (02) : 139 - 139
[43] Texas legitimizes path around FDA oversight
DeFrancesco, Laura
NATURE BIOTECHNOLOGY, 2012, 30 (05) : 379 - 379
[44] Pandemic Alters FDA Inspections and Quality Oversight
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2021, 34 (11) : 8 - 9
[45] FDA issues oversight rules for medicated feed
Cima, Greg
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2015, 247 (02): : 129 - 129
[46] Pandemic Alters FDA Inspections and Quality Oversight
Wechsler, Jill
Pharmaceutical Technology, 2021, 45 (11) : 14 - 15
[47] FDA Realigns Drug Inspection and Manufacturing Oversight
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2014, 27 (12) : 8 - +
[48] FDA Expands Oversight of Cell and Gene Therapies
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2022, 35 (11) : 9 - 9
[49] FDA faulted for lax oversight of foreign drugs
不详
CHEMICAL & ENGINEERING NEWS, 2008, 86 (17) : 34 - 34
[50] FDA Oversight of Cell Therapy Clinical Trials
Au, Patrick
Hursh, Deborah A.
Lim, Agnes
Moos, Malcolm C., Jr.
Oh, Steven S.
Schneider, Bruce S.
Witten, Celia M.
SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (149)

← 1 2 3 4 5 →